These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24264235)

  • 61. Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases.
    Wolf A; Donahue B; Silverman JS; Chachoua A; Lee JK; Kondziolka D
    J Neurooncol; 2017 Aug; 134(1):139-143. PubMed ID: 28536993
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases.
    Dohm AE; Hughes R; Wheless W; Lecompte M; Lanier C; Ruiz J; Watabe K; Xing F; Su J; Cramer C; Laxton A; Tatter S; Chan MD
    J Neurooncol; 2018 Dec; 140(3):749-756. PubMed ID: 30367382
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Stereotactic radiosurgery for cerebral metastatic melanoma.
    Somaza S; Kondziolka D; Lunsford LD; Kirkwood JM; Flickinger JC
    J Neurosurg; 1993 Nov; 79(5):661-6. PubMed ID: 8410244
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Stereotactic radiosurgery for primary malignant spinal tumors.
    Chang UK; Lee DH; Kim MS
    Neurol Res; 2014 Jun; 36(6):597-606. PubMed ID: 24773479
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HFSRT of the resection cavity in patients with brain metastases.
    Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
    Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Dose-Volume Response Model for Brain Metastases Treated With Frameless Single-Fraction Robotic Radiosurgery: Seeking to Better Predict Response to Treatment.
    Amsbaugh MJ; Yusuf MB; Gaskins J; Dragun AE; Dunlap N; Guan T; Woo S
    Technol Cancer Res Treat; 2017 Jun; 16(3):344-351. PubMed ID: 28027696
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation.
    Eaton BR; Gebhardt B; Prabhu R; Shu HK; Curran WJ; Crocker I
    Radiat Oncol; 2013 Jun; 8():135. PubMed ID: 23759065
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Postsurgical Cavity Evolution After Brain Metastasis Resection: How Soon Should Postoperative Radiosurgery Follow?
    Patel RA; Lock D; Helenowski IB; Chandler JP; Sachdev S; Tate MC; Kruser TJ
    World Neurosurg; 2018 Feb; 110():e310-e314. PubMed ID: 29122731
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The cost-effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of brain metastasis in Vietnam from the perspective of patients and families.
    Vuong DA; Rades D; Le AN; Busse R
    World Neurosurg; 2012 Feb; 77(2):321-8. PubMed ID: 22120377
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Postoperative stereotactic radiosurgery for patients with resected brain metastases: a volumetric analysis.
    Patel RA; Lock D; Helenowski IB; Chandler JP; Tate MC; Bloch O; Sachdev S; Kruser TJ
    J Neurooncol; 2018 Nov; 140(2):395-401. PubMed ID: 30084023
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stereotactic radiosurgery for large brain metastases.
    Ebner D; Rava P; Gorovets D; Cielo D; Hepel JT
    J Clin Neurosci; 2015 Oct; 22(10):1650-4. PubMed ID: 26209921
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations.
    Bishop AJ; Tao R; Guadagnolo BA; Allen PK; Rebueno NC; Wang XA; Amini B; Tatsui CE; Rhines LD; Li J; Chang EL; Brown PD; Ghia AJ
    J Neurosurg Spine; 2017 Sep; 27(3):303-311. PubMed ID: 28644075
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection.
    Navarria P; Pessina F; Cozzi L; Ascolese AM; De Rose F; Fogliata A; Franzese C; Franceschini D; Tozzi A; D'Agostino G; Comito T; Iftode C; Maggi G; Reggiori G; Bello L; Scorsetti M
    Radiat Oncol; 2016 Jun; 11():76. PubMed ID: 27249940
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neoadjuvant Stereotactic Radiosurgery Before Surgical Resection of Cerebral Metastases.
    Patel AR; Nedzi L; Lau S; Barnett SL; Mickey BE; Moore W; Bindal S; Wardak Z; Dan T; Timmerman R; Patel TR
    World Neurosurg; 2018 Dec; 120():e480-e487. PubMed ID: 30149167
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED
    Kumar AMS; Miller J; Hoffer SA; Mansur DB; Coffey M; Lo SS; Sloan AE; Machtay M
    J Neurooncol; 2018 Sep; 139(2):449-454. PubMed ID: 29749569
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis.
    Lamba N; Cagney DN; Brigell RH; Martin AM; Besse LA; Catalano PJ; Phillips JG; Pashtan IM; Bi WL; Claus EB; Golby AJ; Dunn IF; Smith TR; Tanguturi SK; Haas-Kogan DA; Alexander BM; Aizer AA
    World Neurosurg; 2019 Feb; 122():e1557-e1561. PubMed ID: 30471438
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.
    Wernicke AG; Hirschfeld CB; Smith AW; Taube S; Yondorf MZ; Parashar B; Nedialkova L; Kulidzhanov F; Trichter S; Sabbas A; Ramakrishna R; Pannullo S; Schwartz TH
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1059-1068. PubMed ID: 28721889
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Local recurrence patterns after postoperative stereotactic radiation surgery to resected brain metastases: A quantitative analysis to guide target delineation.
    Gui C; Moore J; Grimm J; Kleinberg L; McNutt T; Shen C; Chen L; Bettegowda C; Lim M; Redmond KJ
    Pract Radiat Oncol; 2018; 8(6):388-396. PubMed ID: 30029965
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent disease.
    Nanda T; Yaeh A; Wu CC; Jani A; Saad S; Qureshi YH; Cauley KA; Lesser J; Cheng SK; Isaacson SR; Sisti MB; Bruce JN; McKhann GM; Sheth SA; Lassman AB; Wang TJC
    J Neurooncol; 2018 Jan; 136(2):281-287. PubMed ID: 29170908
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Radiosurgery with 20 Gy provides better local contol of 1-3 brain metastases from breast cancer than with lower doses.
    Rades D; Huttenlocher S; Rudat V; Hornung D; Blanck O; Phuong PC; Khoa MT; Schild SE; Fischer D
    Anticancer Res; 2015 Jan; 35(1):333-6. PubMed ID: 25550568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.